▶ 調査レポート

カプロン酸ヒドロキシプロゲステロン注射の世界市場レポート2020

• 英文タイトル:Global Hydroxyprogesterone Caproate Injection Sales Market Report 2020

Global Hydroxyprogesterone Caproate Injection Sales Market Report 2020「カプロン酸ヒドロキシプロゲステロン注射の世界市場レポート2020」(市場規模、市場予測)調査レポートです。• レポートコード:20QY06-01400
• 出版社/出版日:QYResearch / 2020年6月2日
• レポート形態:英文、PDF、136ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥456,000 (USD4,000)▷ お問い合わせ
  Multi User¥684,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥912,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、カプロン酸ヒドロキシプロゲステロン注射のグローバル市場について種類別(1mL注射、5mL注射)、用途別(病院注射、クリニック注射)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・カプロン酸ヒドロキシプロゲステロン注射市場の概要
・世界の主要地域別カプロン酸ヒドロキシプロゲステロン注射市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のカプロン酸ヒドロキシプロゲステロン注射市場規模2015-2026:種類別(1mL注射、5mL注射)
・世界のカプロン酸ヒドロキシプロゲステロン注射市場規模2015-2026:用途別(病院注射、クリニック注射)
・カプロン酸ヒドロキシプロゲステロン注射の北米市場規模2015-2020
・カプロン酸ヒドロキシプロゲステロン注射のヨーロッパ市場規模2015-2020
・カプロン酸ヒドロキシプロゲステロン注射の中国市場規模2015-2020
・カプロン酸ヒドロキシプロゲステロン注射の日本市場規模2015-2020
・カプロン酸ヒドロキシプロゲステロン注射の東南アジア市場規模2015-2020
・カプロン酸ヒドロキシプロゲステロン注射のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(AMAG Pharmaceuticals、Mcguff Pharmaceuticals Inc、Aspen Oss B.V、American Regent, Inc.、Mylan Institutional)
・カプロン酸ヒドロキシプロゲステロン注射の製造コスト分析
・販売チャネル、流通業者、顧客
・カプロン酸ヒドロキシプロゲステロン注射の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Hydroxyprogesterone Caproate Injection Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Hydroxyprogesterone Caproate Injection market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hydroxyprogesterone Caproate Injection market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Hydroxyprogesterone Caproate Injection industry.
Based on our recent survey, we have several different scenarios about the Hydroxyprogesterone Caproate Injection YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 255.2 million in 2019. The market size of Hydroxyprogesterone Caproate Injection will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Hydroxyprogesterone Caproate Injection market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Hydroxyprogesterone Caproate Injection market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Hydroxyprogesterone Caproate Injection market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Hydroxyprogesterone Caproate Injection market. The report also includes nautical information, where it shows Hydroxyprogesterone Caproate Injection market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Hydroxyprogesterone Caproate Injection market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Hydroxyprogesterone Caproate Injection market.
AMAG Pharmaceuticals is the leading manufacturer worldwide with the revenue market share of 83%, followed by Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Inc., and Mylan Institutional. North America and Europe are the two biggest selling regions, with the combined sales market share of 72%. In the forecast period, Asia-Pacific is expected to see the rapidest development.
Geographical Analysis:
Based on region, the global Hydroxyprogesterone Caproate Injection market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Hydroxyprogesterone Caproate Injection market are
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V
American Regent, Inc.
Mylan Institutional

Segment by Type
1 mL Injection
5 mL Injection
The 5 mL Injection accounted for a larger market share of 52% in 2018, but it was projected to be exceeded by the 1mL one in 2025.
Segment by Application
Hospitals Injection
Clinics Injection
Hospital took a larger market share of 51% in 2018, but it was expected to be exceeded by the Clinic in 2025.
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Hydroxyprogesterone Caproate Injection market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Hydroxyprogesterone Caproate Injection market.
• The market share of the global Hydroxyprogesterone Caproate Injection market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Hydroxyprogesterone Caproate Injection market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Hydroxyprogesterone Caproate Injection market.

レポート目次

1 Hydroxyprogesterone Caproate Injection Market Overview
1.1 Hydroxyprogesterone Caproate Injection Product Scope
1.2 Hydroxyprogesterone Caproate Injection Segment by Type
1.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2020-2026)
1.2.2 1 mL Injection
1.2.3 5 mL Injection
1.3 Hydroxyprogesterone Caproate Injection Segment by Application
1.3.1 Global Hydroxyprogesterone Caproate Injection Sales Comparison by Application (2020-2026)
1.3.2 Hospitals Injection
1.3.3 Clinics Injection
1.4 Hydroxyprogesterone Caproate Injection Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hydroxyprogesterone Caproate Injection Sales Growth Rate (2015-2026)
1.4.2 Global Hydroxyprogesterone Caproate Injection Revenue and Growth Rate (2015-2026)
1.4.3 Global Hydroxyprogesterone Caproate Injection Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Hydroxyprogesterone Caproate Injection Industry Impact
1.5.1 How the Covid-19 is Affecting the Hydroxyprogesterone Caproate Injection Industry
1.5.1.1 Hydroxyprogesterone Caproate Injection Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Hydroxyprogesterone Caproate Injection Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Hydroxyprogesterone Caproate Injection Players to Combat Covid-19 Impact

2 Hydroxyprogesterone Caproate Injection Estimate and Forecast by Region
2.1 Global Hydroxyprogesterone Caproate Injection Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hydroxyprogesterone Caproate Injection Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2015-2020)
2.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2015-2020)
2.3 Global Hydroxyprogesterone Caproate Injection Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hydroxyprogesterone Caproate Injection Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hydroxyprogesterone Caproate Injection Estimates and Projections (2015-2026)
2.4.2 Europe Hydroxyprogesterone Caproate Injection Estimates and Projections (2015-2026)
2.4.3 China Hydroxyprogesterone Caproate Injection Estimates and Projections (2015-2026)
2.4.4 Japan Hydroxyprogesterone Caproate Injection Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hydroxyprogesterone Caproate Injection Estimates and Projections (2015-2026)
2.4.6 India Hydroxyprogesterone Caproate Injection Estimates and Projections (2015-2026)
3 Global Hydroxyprogesterone Caproate Injection Competition Landscape by Players
3.1 Global Top Hydroxyprogesterone Caproate Injection Players by Sales (2015-2020)
3.2 Global Top Hydroxyprogesterone Caproate Injection Players by Revenue (2015-2020)
3.3 Global Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hydroxyprogesterone Caproate Injection as of 2019)
3.4 Global Hydroxyprogesterone Caproate Injection Average Price by Company (2015-2020)
3.5 Manufacturers Hydroxyprogesterone Caproate Injection Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hydroxyprogesterone Caproate Injection Players (Opinion Leaders)
4 Global Hydroxyprogesterone Caproate Injection Market Size by Type
4.1 Global Hydroxyprogesterone Caproate Injection Historic Market Review by Type (2015-2020)
4.1.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
4.1.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2015-2020)
4.1.3 Global Hydroxyprogesterone Caproate Injection Price by Type (2014-2020)
4.2 Global Hydroxyprogesterone Caproate Injection Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Type (2021-2026)
4.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Type (2021-2026)
4.2.3 Global Hydroxyprogesterone Caproate Injection Price Forecast by Type (2021-2026)
5 Global Hydroxyprogesterone Caproate Injection Market Size by Application
5.1 Global Hydroxyprogesterone Caproate Injection Historic Market Review by Application (2015-2020)
5.1.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)
5.1.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2015-2020)
5.1.3 Global Hydroxyprogesterone Caproate Injection Price by Application (2015-2020)
5.2 Global Hydroxyprogesterone Caproate Injection Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Application (2021-2026)
5.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Application (2021-2026)
5.2.3 Global Hydroxyprogesterone Caproate Injection Price Forecast by Application (2021-2026)

3 North America Hydroxyprogesterone Caproate Injection Market Facts & Figures
3.2 North America Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
3.3 North America Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
3.4 North America Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)

4 Europe Hydroxyprogesterone Caproate Injection Market Facts & Figures
4.2 Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
4.3 Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
4.4 Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)

5 China Hydroxyprogesterone Caproate Injection Market Facts & Figures
5.2 China Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
5.3 China Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
5.4 China Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)

6 Japan Hydroxyprogesterone Caproate Injection Market Facts & Figures
6.2 Japan Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
6.3 Japan Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
6.4 Japan Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)

7 Southeast Asia Hydroxyprogesterone Caproate Injection Market Facts & Figures
7.2 Southeast Asia Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)

8 India Hydroxyprogesterone Caproate Injection Market Facts & Figures
8.2 India Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
8.3 India Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
8.4 India Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Hydroxyprogesterone Caproate Injection Business
12.1 AMAG Pharmaceuticals
12.1.1 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Corporation Information
12.1.2 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Business Overview and Total Revenue
12.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Products Offered
12.1.5 AMAG Pharmaceuticals Recent Development
12.2 Mcguff Pharmaceuticals Inc
12.2.1 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Corporation Information
12.2.2 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Business Overview and Total Revenue
12.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Products Offered
12.2.5 Mcguff Pharmaceuticals Inc Recent Development
12.3 Aspen Oss B.V
12.3.1 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Corporation Information
12.3.2 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Business Overview and Total Revenue
12.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Products Offered
12.3.5 Aspen Oss B.V Recent Development
12.4 American Regent, Inc.
12.4.1 American Regent, Inc. Hydroxyprogesterone Caproate Injection Corporation Information
12.4.2 American Regent, Inc. Hydroxyprogesterone Caproate Injection Business Overview and Total Revenue
12.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2015-2020)
12.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Products Offered
12.4.5 American Regent, Inc. Recent Development
12.5 Mylan Institutional
12.5.1 Mylan Institutional Hydroxyprogesterone Caproate Injection Corporation Information
12.5.2 Mylan Institutional Hydroxyprogesterone Caproate Injection Business Overview and Total Revenue
12.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Products Offered
12.5.5 Mylan Institutional Recent Development

13 Hydroxyprogesterone Caproate Injection Manufacturing Cost Analysis
13.1 Hydroxyprogesterone Caproate Injection Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hydroxyprogesterone Caproate Injection
13.4 Hydroxyprogesterone Caproate Injection Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hydroxyprogesterone Caproate Injection Distributors List
14.3 Hydroxyprogesterone Caproate Injection Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Hydroxyprogesterone Caproate Injection Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Hydroxyprogesterone Caproate Injection Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Hydroxyprogesterone Caproate Injection Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Hydroxyprogesterone Caproate Injection Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Hydroxyprogesterone Caproate Injection Players to Combat Covid-19 Impact
Table 8. Global Market Hydroxyprogesterone Caproate Injection Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Region (2015-2020)
Table 10. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2015-2020)
Table 11. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Hydroxyprogesterone Caproate Injection Revenue Share by Region (2015-2020)
Table 13. Global Hydroxyprogesterone Caproate Injection Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Hydroxyprogesterone Caproate Injection Revenue Share Forecast by Region (2021-2026)
Table 17. Global Hydroxyprogesterone Caproate Injection (K Units) of Key Companies (2015-2020)
Table 18. Global Hydroxyprogesterone Caproate Injection Sales Share by Company (2015-2020)
Table 19. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Hydroxyprogesterone Caproate Injection Revenue Share by Company (2015-2020)
Table 21. Global Hydroxyprogesterone Caproate Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hydroxyprogesterone Caproate Injection as of 2019)
Table 22. Global Hydroxyprogesterone Caproate Injection Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Hydroxyprogesterone Caproate Injection Manufacturing Sites and Area Served
Table 24. Manufacturers Hydroxyprogesterone Caproate Injection Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Hydroxyprogesterone Caproate Injection Players
Table 27. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2015-2020)
Table 28. Global Hydroxyprogesterone Caproate Injection Sales Share by Type (2015-2020)
Table 29. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Hydroxyprogesterone Caproate Injection Price (K Units) by Type (2015-2020)
Table 31. Global Hydroxyprogesterone Caproate Injection Sales Share by Type (2021-2026)
Table 32. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Hydroxyprogesterone Caproate Injection Revenue Share by Type (2021-2026)
Table 34. Global Hydroxyprogesterone Caproate Injection Price (K Units) by Type (2021-2026)
Table 35. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2015-2020)
Table 36. Global Hydroxyprogesterone Caproate Injection Sales Share by Application (2015-2020)
Table 37. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Hydroxyprogesterone Caproate Injection Price (K Units) by Application (2015-2020)
Table 39. Global Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2021-2026)
Table 40. Global Hydroxyprogesterone Caproate Injection Sales Share by Application (2021-2026)
Table 41. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Hydroxyprogesterone Caproate Injection Revenue Share by Application (2021-2026)
Table 43. Global Hydroxyprogesterone Caproate Injection Price (K Units) by Application (2021-2026)
Table 44. United States Hydroxyprogesterone Caproate Injection Sales (K Units) by Company (2015-2020)
Table 45. United States Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
Table 46. United States Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2015-2020)
Table 47. United States Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
Table 48. United States Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2015-2020)
Table 49. United States Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)
Table 50. Europe Hydroxyprogesterone Caproate Injection Sales (K Units) by Company (2015-2020)
Table 51. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
Table 52. Europe Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2015-2020)
Table 53. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
Table 54. Europe Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2015-2020)
Table 55. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
Table 56. China Hydroxyprogesterone Caproate Injection Sales (K Units) by Company (2015-2020)
Table 57. China Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
Table 58. China Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2015-2020)
Table 59. China Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
Table 60. China Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2015-2020)
Table 61. China Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)
Table 62. Japan Hydroxyprogesterone Caproate Injection Sales (K Units) by Company (2015-2020)
Table 63. Japan Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
Table 64. Japan Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2015-2020)
Table 65. Japan Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
Table 66. Japan Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2015-2020)
Table 67. Japan Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Hydroxyprogesterone Caproate Injection Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)
Table 74. India Hydroxyprogesterone Caproate Injection Sales (K Units) by Company (2015-2020)
Table 75. India Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2015-2020)
Table 76. India Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2015-2020)
Table 77. India Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2015-2020)
Table 78. India Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2015-2020)
Table 79. India Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2015-2020)
Table 80. AMAG Pharmaceuticals Corporation Information
Table 81. AMAG Pharmaceuticals Description and Business Overview
Table 82. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product
Table 84. AMAG Pharmaceuticals Recent Development
Table 85. Mcguff Pharmaceuticals Inc Corporation Information
Table 86. Mcguff Pharmaceuticals Inc Description and Business Overview
Table 87. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product
Table 89. Mcguff Pharmaceuticals Inc Recent Development
Table 90. Aspen Oss B.V Corporation Information
Table 91. Aspen Oss B.V Description and Business Overview
Table 92. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product
Table 94. Aspen Oss B.V Recent Development
Table 95. American Regent, Inc. Corporation Information
Table 96. American Regent, Inc. Description and Business Overview
Table 97. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product
Table 99. American Regent, Inc. Recent Development
Table . Mylan Institutional Corporation Information
Table . Mylan Institutional Description and Business Overview
Table . Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Mylan Institutional Hydroxyprogesterone Caproate Injection Product
Table . Mylan Institutional Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Hydroxyprogesterone Caproate Injection Distributors List
Table 108. Hydroxyprogesterone Caproate Injection Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Hydroxyprogesterone Caproate Injection Product Picture
Figure 2. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hydroxyprogesterone Caproate Injection Market Share by Application in 2020 & 2026
Figure 6. Hospitals Injection Examples
Figure 7. Clinics Injection Examples
Figure 8. Global Hydroxyprogesterone Caproate Injection Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Hydroxyprogesterone Caproate Injection Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Hydroxyprogesterone Caproate Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Hydroxyprogesterone Caproate Injection Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Hydroxyprogesterone Caproate Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Hydroxyprogesterone Caproate Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Hydroxyprogesterone Caproate Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Hydroxyprogesterone Caproate Injection Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Hydroxyprogesterone Caproate Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Hydroxyprogesterone Caproate Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Hydroxyprogesterone Caproate Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Hydroxyprogesterone Caproate Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Hydroxyprogesterone Caproate Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Hydroxyprogesterone Caproate Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Hydroxyprogesterone Caproate Injection Players Market Share by Revenue in Hydroxyprogesterone Caproate Injection 2015 & 2019
Figure 26. Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Hydroxyprogesterone Caproate Injection Revenue Share by Type (2015-2020)
Figure 28. Global Hydroxyprogesterone Caproate Injection Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Hydroxyprogesterone Caproate Injection Revenue Share by Application (2015-2020)
Figure 30. Global Hydroxyprogesterone Caproate Injection Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2019
Figure 32. United States Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2019
Figure 33. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Company in 2019
Figure 34. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2019
Figure 35. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Application in 2019
Figure 36. China Hydroxyprogesterone Caproate Injection Sales Market Share by Company in 2019
Figure 37. China Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2019
Figure 38. China Hydroxyprogesterone Caproate Injection Sales Market Share by Application in 2019
Figure 39. Japan Hydroxyprogesterone Caproate Injection Sales Market Share by Company in 2019
Figure 40. Japan Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2019
Figure 41. Japan Hydroxyprogesterone Caproate Injection Sales Market Share by Application in 2019
Figure 42. Southeast Asia Hydroxyprogesterone Caproate Injection Sales Market Share by Company in 2019
Figure 43. Southeast Asia Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2019
Figure 44. Southeast Asia Hydroxyprogesterone Caproate Injection Sales Market Share by Application in 2019
Figure 45. India Hydroxyprogesterone Caproate Injection Sales Market Share by Company in 2019
Figure 46. India Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2019
Figure 47. India Hydroxyprogesterone Caproate Injection Sales Market Share by Application in 2019
Figure 48. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Mcguff Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Aspen Oss B.V Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. American Regent, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Mylan Institutional Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Hydroxyprogesterone Caproate Injection
Figure 55. Manufacturing Process Analysis of Hydroxyprogesterone Caproate Injection
Figure 56. Hydroxyprogesterone Caproate Injection Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed